X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5129) 5129
Newsletter (1813) 1813
Book Review (567) 567
Publication (389) 389
Newspaper Article (166) 166
Magazine Article (49) 49
Conference Proceeding (17) 17
Trade Publication Article (11) 11
Book Chapter (8) 8
Transcript (6) 6
Book / eBook (5) 5
Dissertation (3) 3
Government Document (1) 1
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4381) 4381
prediabetic state (4359) 4359
humans (3892) 3892
male (2926) 2926
female (2921) 2921
glucose (2238) 2238
diabetes (2166) 2166
endocrinology & metabolism (2128) 2128
middle aged (2125) 2125
adult (1907) 1907
type 2 diabetes (1834) 1834
research (1714) 1714
risk factors (1577) 1577
dextrose (1575) 1575
insulin resistance (1491) 1491
prediabetic state - blood (1273) 1273
glucose metabolism (1263) 1263
aged (1247) 1247
blood glucose - metabolism (1156) 1156
glucose tolerance test (1148) 1148
obesity (1065) 1065
insulin (873) 873
analysis (860) 860
animals (849) 849
diabetes mellitus (810) 810
prediabetic state - epidemiology (810) 810
prediabetic state - diagnosis (804) 804
prevalence (801) 801
prediabetic state - metabolism (800) 800
physiological aspects (731) 731
insulin-resistance (730) 730
risk (714) 714
prediabetes (684) 684
medical research (668) 668
prevention (668) 668
reports (645) 645
body mass index (632) 632
medicine, experimental (624) 624
prediabetic state - physiopathology (607) 607
blood glucose - analysis (581) 581
adolescent (570) 570
insulin - blood (566) 566
mellitus (566) 566
metabolic syndrome (565) 565
diabetes mellitus, type 2 - blood (556) 556
cross-sectional studies (548) 548
glucose tolerance tests (545) 545
impaired glucose-tolerance (531) 531
health aspects (511) 511
prediabetic state - complications (509) 509
insulin - metabolism (507) 507
abridged index medicus (504) 504
diabetes therapy (477) 477
development and progression (471) 471
diabetes mellitus, type 2 - epidemiology (468) 468
hyperglycemia (461) 461
blood sugar (456) 456
fasting (456) 456
internal medicine (444) 444
medicine & public health (437) 437
diagnosis (421) 421
metabolism (410) 410
young adult (407) 407
care and treatment (397) 397
insulin secretion (393) 393
mice (382) 382
adults (377) 377
rats (365) 365
diabetes mellitus, type 2 - prevention & control (361) 361
population (360) 360
child (359) 359
glycosylated hemoglobin (358) 358
hypertension (354) 354
biomarkers - blood (345) 345
diabetes-mellitus (340) 340
prediabetic state - drug therapy (333) 333
diabetes mellitus, type 2 - metabolism (329) 329
cardiovascular-disease (325) 325
time factors (316) 316
follow-up studies (313) 313
glycated hemoglobin a - metabolism (308) 308
studies (305) 305
exercise (304) 304
impaired fasting glucose (301) 301
diabetes mellitus, type 2 - diagnosis (298) 298
mortality (298) 298
diabetics (293) 293
medicine (291) 291
body weight (285) 285
metabolic diseases (284) 284
prospective studies (281) 281
diabetes mellitus - epidemiology (280) 280
research article (279) 279
association (276) 276
epidemiology (273) 273
disease (270) 270
article (267) 267
pregnancy (267) 267
cohort studies (266) 266
hypoglycemic agents - therapeutic use (266) 266
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6820) 6820
German (110) 110
Russian (53) 53
French (49) 49
Italian (26) 26
Spanish (26) 26
Chinese (17) 17
Korean (17) 17
Polish (15) 15
Japanese (9) 9
Czech (6) 6
Hungarian (6) 6
Swedish (6) 6
Romanian (3) 3
Ukrainian (3) 3
Croatian (2) 2
Portuguese (2) 2
Turkish (2) 2
Bulgarian (1) 1
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FEBS Journal, ISSN 1742-464X, 2014, Volume 281, Issue 3, pp. 739 - 749
Journal Article
Diabetes, ISSN 0012-1797, 11/2012, Volume 61, Issue 11, pp. 2881 - 2892
Macrophages are multifunctional immune cells that may either drive or modulate disease pathogenesis depending on their activation phenotype. Autoimmune type 1... 
ACTIVATION | TOLERANCE | QUANTIFICATION | INFLAMMATION | IN-VIVO | MOUSE | ENDOCRINOLOGY & METABOLISM | REGULATORY T-CELLS | ANTIGENS | IL-10 | BETA | Prediabetic State - metabolism | Macrophages - transplantation | Cell Proliferation | Lymph Nodes - pathology | Diabetes Mellitus, Type 1 - prevention & control | Diabetes Mellitus, Type 1 - metabolism | RNA, Messenger - metabolism | Prediabetic State - therapy | Cell Tracking | Insulin-Secreting Cells - metabolism | Prediabetic State - immunology | Interleukin-10 - metabolism | Female | Prediabetic State - pathology | Diabetes Mellitus, Type 1 - immunology | Macrophages - immunology | Immunotherapy, Adoptive | Interferon-gamma Release Tests | Interleukin-4 - metabolism | Cells, Cultured | Diabetes Mellitus, Type 1 - pathology | Gene Expression Regulation | Lymph Nodes - metabolism | Pancreas - pathology | Mice, Transgenic | Lymph Nodes - immunology | Pancreas - metabolism | Pancreas - immunology | Insulin-Secreting Cells - immunology | Macrophage Activation | Macrophages - metabolism | Animals | Mice, Inbred NOD | Mice | Insulin-Secreting Cells - pathology | Transforming Growth Factor beta - metabolism | Research | Macrophages | Type 1 diabetes | Analysis | Index Medicus | Abridged Index Medicus | Immunology and Transplantation | Basic Medicine | Immunologi inom det medicinska området | Medical and Health Sciences | Medicin och hälsovetenskap | Immunology in the medical area | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Diabetes Care, ISSN 0149-5992, 04/2012, Volume 35, Issue 4, pp. 873 - 878
OBJECTIVE-Prediabetes and type 2 diabetes mellitus (T2DM) are believed to be common and associated with a worse metabolic profile in patients with nonalcoholic... 
LIPOTOXICITY | PATHOGENESIS | OBESITY | ACIDS | INSULIN-RESISTANCE | GLUCOSE | ENDOCRINOLOGY & METABOLISM | STEATOHEPATITIS | SECRETION | MELLITUS | Diabetes Mellitus - blood | Prediabetic State - metabolism | Overweight - complications | Prevalence | Humans | Middle Aged | Fatty Liver - complications | Hyperglycemia - complications | Male | Obesity - blood | Case-Control Studies | Overweight - metabolism | Overweight - epidemiology | Non-alcoholic Fatty Liver Disease | Diabetes Complications - epidemiology | Adult | Female | Prediabetic State - epidemiology | Prediabetic State - blood | Fatty Liver - metabolism | Fatty Liver - blood | Obesity - complications | Diabetes Complications - metabolism | Metabolome - physiology | Diabetes Mellitus - metabolism | Prediabetic State - complications | Diabetes Complications - blood | Obesity - metabolism | Hyperglycemia - metabolism | Hyperglycemia - blood | Overweight - blood | Diabetes Mellitus - epidemiology | Obesity - epidemiology | Hyperglycemia - epidemiology | Fatty Liver - epidemiology | Type 2 diabetes | Medical research | Liver diseases | Development and progression | Research | Glucose | Insulin | Glucose tolerance tests | Fatty acids | Dextrose | Prevalence studies (Epidemiology) | Fatty liver | Medicine, Experimental | Prediabetic state | Hyperglycemia | Diabetes | Metabolism | Index Medicus | Original Research
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 05/2013, Volume 98, Issue 5, pp. 2053 - 2061
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2016, Volume 11, Issue 5, pp. e0155108 - e0155108
Background The regulation of microRNAs (miRNAs) at different stages of the progression of type 2 diabetes mellitus (T2DM) and their role in glucose homeostasis... 
OFFSPRING HYPERPHAGIA | MITOCHONDRIAL BIOGENESIS | PHOSPHORYLATION | INSULIN-RESISTANCE | MULTIDISCIPLINARY SCIENCES | GLYCOGEN-SYNTHASE KINASE-3 | DISEASE | RATS | LEADS | ADIPOSITY | DIET-INDUCED OBESITY | Prediabetic State - metabolism | Prediabetic State - genetics | Diabetes Mellitus, Type 2 - genetics | Humans | Diet, High-Fat - adverse effects | Male | MicroRNAs - metabolism | Muscle, Skeletal - metabolism | Diabetes Mellitus, Type 2 - metabolism | Proto-Oncogene Proteins c-akt - genetics | Myoblasts - metabolism | Glycogen - metabolism | Female | Prediabetic State - pathology | Prediabetic State - etiology | Proto-Oncogene Proteins c-akt - metabolism | Disease Models, Animal | Cell Line | Signal Transduction | Mice, Inbred C57BL | Gene Expression Regulation | Insulin Resistance | Oxidative Phosphorylation | Rats | Mitochondria - metabolism | Glycogen Synthase Kinase 3 - metabolism | Myoblasts - pathology | Rats, Sprague-Dawley | Insulin - metabolism | Animals | Glycogen Synthase Kinase 3 - genetics | Glucose - metabolism | MicroRNAs - genetics | Diabetes Mellitus, Type 2 - pathology | Muscle, Skeletal - pathology | Type 2 diabetes | Glucose metabolism | Complications and side effects | MicroRNA | Genetic aspects | Research | Comparative analysis | Diabetes therapy | Heart | Plasma | Phosphorylation | Sucrose | Homeostasis | AKT protein | Biosynthesis | Glucose | High fat diet | Proteins | Mitochondria | Control | Rodents | Oxidation | Diabetes mellitus (non-insulin dependent) | Medical research | Obesity | Glycogen | Diabetes mellitus | MiRNA | Muscles | Metabolism | Gene expression | Insulin | Patients | Skeletal muscle | Pregnancy | Musculoskeletal system | Progeny | Offspring | Oxidative phosphorylation | Ribonucleic acids | Biopsy | MicroRNAs | Glycolysis | Insulin resistance | Diabetes | Lactic acid | Laboratory animals | Index Medicus
Journal Article
Journal Article
Diabetologia, ISSN 0012-186X, 11/2018, Volume 61, Issue 11, pp. 2386 - 2397
The aim of this study was to evaluate the effect of sitagliptin on glucose tolerance, plasma lipids, energy expenditure and metabolism of brown adipose tissue... 
Obesity | DPP4 inhibitor | Energy expenditure | Brown adipose tissue | Dyslipidaemia | Prediabetes | Diabetes risk | Skeletal muscle | HEALTHY HUMANS | IMPAIRED GLUCOSE-TOLERANCE | INSULIN SENSITIVITY | OXIDATIVE-METABOLISM | BETA-CELL FUNCTION | FASTING GLUCOSE | ENDOCRINOLOGY & METABOLISM | RESISTANCE | INHIBITOR | TYPE-2 DIABETES-MELLITUS | SOUTH ASIANS | Prediabetic State - metabolism | Double-Blind Method | Overweight - drug therapy | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Adipose Tissue, White - metabolism | Body Weight - drug effects | Male | Muscle, Skeletal - metabolism | Prediabetic State - drug therapy | Blood Glucose - drug effects | Carrier Proteins - genetics | Overweight - metabolism | Muscle, Skeletal - drug effects | Sitagliptin Phosphate - therapeutic use | Adult | Adipose Tissue, Brown - drug effects | Adipose Tissue, Brown - metabolism | Adipose Tissue, White - drug effects | Energy Metabolism - drug effects | Adipose tissues | Physiological aspects | Clinical trials | Analysis | Prediabetic state | Energy metabolism | Adipose tissue | Fasting | Oxidative metabolism | Diabetes mellitus | Body weight | Glucose | Gene expression | Metabolism | Body composition | Lipoproteins (very low density) | Glucose tolerance | Glucose metabolism | Musculoskeletal system | Mitochondria | Diabetes | Lipid metabolism | Adipose tissue (brown) | Diabetes mellitus (non-insulin dependent) | Index Medicus
Journal Article
Diabetes Care, ISSN 0149-5992, 12/2012, Volume 35, Issue 12, pp. 2650 - 2664
Journal Article